Head of Benefit‑Risk & Real‑World Epidemiology

Sanofi; France; À distance; EUR 180 000 - 240 000; Plein temps

Résumé du poste

Sanofi seeks a Head of Benefit-Risk and Pharmacoepidemiology to lead epidemiology and benefit-risk strategies across all GBUs, including data-driven safety signal management. You will drive innovations in methods and tools, guide external partnerships with regulators and academia, and oversee studies that inform regulatory decisions throughout the product lifecycle.

The role requires extensive leadership, deep regulatory knowledge, and a track record in pharmacoepidemiology, with up to 25%

Qualifications

• PhD or MD with advanced degree preferred in Biomedical Sciences or Public Health.
• 15+ years in Epidemiology, Benefit-Risk, Risk Management and safety sciences.
• 8+ years in pharmaceutical industry; travel up to 25% expected.
• Proven leadership in external partnerships and regulatory interactions.
• Strong publication record and ability to educate stakeholders.

Responsabilités

• Lead Epidemiology and BR strategies for regulatory and internal decision making.
• Oversee BR studies, safety risk assessments and PASS activities.
• Shape external partnerships and policies with regulators and academia.
• Develop and implement RWE-based methods and tools for safety evaluation.
• Provide leadership to a large multidisciplinary Epi & BR team.

Connaissances

Leadership

Epidemiology

Benefit–Risk evaluation

Biostatistics

Strategic thinking

Team management

External partnerships

Regulatory knowledge

Problem solving

Communication

Formation

Ph.D. in Biomedical Sciences or Public Health (preferred)

MD with advanced degree in Biomedical Sciences or Public Health

Outils

R (Real-World Evidence analytics)

SAS or similar statistics software

Description du poste

Sanofi seeks a Head of Benefit-Risk and Pharmacoepidemiology to lead epidemiology and benefit-risk strategies across all GBUs, including data-driven safety signal management. You will drive innovations in methods and tools, guide external partnerships with regulators and academia, and oversee studies that inform regulatory decisions throughout the product lifecycle.

The role requires extensive leadership, deep regulatory knowledge, and a track record in pharmacoepidemiology, with up to 25%